16
KESHTOV et al.
Table 2. Spectral characteristics of intermediate and final compounds
Com-
pound spectra,
no.
ν, cm–1
Raman
1H NMR spectra,
13C NMR spectra,
δ, ppm
δ, ppm
Ia
2202 (C≡C) 7.20 (s, 2H), 7.38 (m, 6H), 7.56 (m, 4H) 82.17 (C≡C), 93.95 (C≡C), 122.42 (C), 124.48 (C),
128.27 (CH), 128.53 (CH), 131.34 (CH), 131.71 (CH)
Ib
Ic
2202 (C≡C) 7.43 (m, 6H), 7.58 (m, 4H), 7.65 (d, 2H), 89.79 (C≡C), 119.21 (C), 122.61 (C), 123.76 (CH), 125.62 (CH),
8.03 (d, 2H), 8.63 (s, 2H)
129.10 (CH), 130.36 (CH), 131.63 (CH), 134.95 (C), 139.67 (C)
2210 (C≡C) 7.38 (m, 8H), 7.62 (d, 4H), 7.68 (d, 2H), 87.5 (C≡C), 90.9 (C≡C), 108.4 (CH), 113.6 (C), 122.3 (C),
8.31 (s, 2H, ), 4.33 (m, 2H, CH2),
1.45 (t, 3H, CH3)
123.5 (CH), 123.9 (CH), 127.6 (CH), 128.1 (CH), 129.4 (CH),
131.2 (CH), 139.6 (C), 37.5 (CH2), 13.5 (CH3)
IIa 1681 (C=O) 7.54 (t, 4H ), 7.69 (t, 2H), 7.84 (s, 2H), 128.94 (CH), 130.25 (CH), 131.93 (C), 135.18 (CH),
8.05 (d, 4H)
135.76 (CH), 146.11 (C), 184.97 (C=O), 190.57 (C=O)
IIb 1675 (C=O) 7.63 (t, 4H),7.76 (t, 2H), 7.98 (d, 4H),
126.40 (CH), 125.61 (CH), 126.70 (C), 129.020 (CH),
8.04 (d, 2H), 8.29 (d, 2H), 9.05 (s, 2H) 129.89 (CH), 130.71 (CH), 132.36 (C), 134.29 (CH),
148.04 (C), 148.38 (C), 194.27 (CO), 194.57 (CO)
IIc 1661 (C=O) 7.53 (t, 6H), 7.67 (t, 2H), 8.04 (d, 4H), 109.4 (CH), 122.9 (C), 124.1 (CH), 125.5 (C), 128.1 (CH),
8.21 (d, 2H), 8.66 (s, 2H), 4.44 (m, 2H, 129.01 (CH), 129.7 (CH), 132.9 (C), 134.5 (CH), 144.1 (C),
CH2), 1.48 (m, 3H CH3)
193.6 (C), 194.7 (Cé), 38.1 (CH2), 13.5 (CH3)
IIIa 1711 (C=O) 7.25–7.38 (m, 20H), 7.43 (s, 2H),
200.14 (CO), 164.05 (C), 157.04 (C), 145.27 (C), 139.12 (C),
137.07 (C), 134.84 (C), 133.14 (C), 122.26 (C), 132.48 (CH),
131.93 (CH), 127.57 (CH), 126.78 (CH), 126.38 (CH),
126.13 (CH), 126.08 (CH), 125.85 (CH), 124.85 (CH)
7.58–7.77 (m, 8H)
IIIb 1711 (C=O) 6.90 (d, 6H), 7.05 (d, 4H), 7.13 (d, 8H), 200.16 (CO), 154.34 (C), 153.75 (C), 139.74 (C), 134.84 (C),
7.15–7.30 (m, 16H), 7.60 (d, 2H)
132.98 (C), 130.51 (C), 129.61 (C), 125.29 (C), 125.21 (C),
130.02 (CH), 129.97 (CH), 129.09 (CH), 128.42 (CH), 127.99
(CH), 127.53 (CH), 127.42 (CH), 122.34 (CH), 122.11 (CH)
IIIc 1710 (C=O) 6.9–7.26 (m, 36H, Ar), 1.45 (m, 3H, CH3), 200.29 (CO), 155.07 (C), 154.34 (C), 140.08 (C), 133.31 (C),
4.25 (m, 2H, CH2)
131.20 (C), 130.79 (C), 125.52 (C), 124.21 (C), 123.77 (C),
122.21 (C), 130.07 (CH), 129.27 (CH), 128.29 (CH), 127.87
(CH), 127.76 (CH), 127.26 (CH), 127.11 (CH), 121.70
(CH), 108.03 (CH), 37.76 (CH2), 13.81 (CH3)
IVd 2191 (C≡C) 7.16 (m, 2H), 7.46 (m, 2H), 7.61 (s, 4H), 85.42 (C≡C), 93.10 (C≡C), 122.76 (C), 123.41 (C), 128.57 (CH),
7.72 (m, 2H) 129.87 (CH), 132.27 (CH), 133.81 (CH)
IVe 2191 (C≡C) 7.50 (t, 2H), 7.58 (t, 2H), 7.68 (s, 4H), 85.07 (C≡C), 91.62 (C≡C), 118.18 (C), 122.69 (C), 123.07 (C),
7.78 (s, 2H), 7.95 (d, 2H), 8.13 (d, 2H) 123.11 (CH), 124.83 (CH), 125.18 (CH), 130.21 (CH),
131.67 (CH), 131.73 (CH), 138.88 (CH), 139.09 (CH)
Vd 1681 (CO) 7.39 (m, 2H), 8.06 (m, 2H), 8.25 (s, 4H), 131.29 (CH), 137.67 (C), 139.00 (CH), 139.59 (CH),
8.38 (m, 2H)
139.72, 185.69 (CO), 192.27 (CO)
Ve 1680 (C=O) 7.65 (t, 2H), 7.72 (t, 2H), 8.28 (d, 2H), 124.54 (C), 124.70 (C), 128.32 (C), 129.65 (C), 129.87 (C),
8.36 (s, 4H), 8.82 (d, 2H), 9.14 (s, 2H) 130.08 (C), 132.69 (CH), 135.12 (CH), 135.69 (C),
146.59 (CH), 194.46 (CO), 194.54 (CO)
VId 1709 (C=O) 7.10–7.70 (m, 26H), 7.72 (s, 4H)
122.26 (C), 124.86 (CH), 125.70 (CH), 125.85 (CH), 126.13
(CH), 126.25 (CH), 126.38 (CH), 129.17 (CH), 131.80
(CH), 131.93 (CH), 132.48 (CH), 133.50 (C), 134.84 (C),
137.06 (C), 139.11 (C), 143.84 (C), 155.30 (C), 156.86 (C),
200.14 (CO)
VIe 1709 (C=O) 6.73 (s, 4H), 7.00–7.29 (m, 28H, Ar),
199.98 (CO), 153.39 (C), 148.03 (C), 139.63 (C), 136.32 (C),
133.35 (C), 130.66 (C), 130.22 (C), 128.93 (C), 126.03 (C),
125.28 (C), 129.93 (CH), 129.30 (CH), 128.70 (CH), 127.99
(CH), 127.93 (CH), 127.63 (CH), 127.39 (CH), 124.45
(CH), 123.95 (CH), 123.77 (CH), 122.45 (CH)
7.83 (d, 2H)
1,4-bis(hetarylglyoxalyl)phenylenes (BHGPs) Vd and
It is worth noting that the intermediate compounds
Ve, and the treatment of BHGPs with a twofold molar formed in the course of the synthesis of BTACPDs
amount of 1,3-diphenylacetone to give BTACPDs VId (Schemes 1, 2), namely, BPEHAs Ia–Ic, BPGHAs IIa–
and VIe [1, 2, 4, 6].
IIc, BHEPs IVd and IVe, and BHGPs Vd and Ve, are
DOKLADY CHEMISTRY Vol. 412 Part 1 2007